Literature DB >> 3593364

Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity.

D W Montgomery, C F Zukoski, G N Shah, A R Buckley, T Pacholczyk, D H Russell.   

Abstract

Culture supernatants from concanavalin A activated murine splenic mononuclear cells (splenocytes) were assayed for prolactin-like molecules using the Nb2 node lymphoma bioassay and immunostaining procedures. Con A stimulated splenocytes produced a factor with prolactin-like immunoreactivity that was mitogenic for Nb2 lymphoma cells. This factor first appeared in culture supernatants with the onset of lymphocyte mitogenesis and its activity was proportional to the number of cells cultured. In addition, splenocyte proliferation was inhibited by antiserum to rat prolactin, and this inhibition was partially reversed by added hormone. These findings show that murine splenocytes produce a substance with prolactin-like activity and suggest that this factor is essential for lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593364     DOI: 10.1016/0006-291x(87)91020-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling.

Authors:  Nithya Krishnan; Huiqi Pan; Donna J Buckley; Arthur Buckley
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

Review 2.  The role of prolactin in the pathogenesis of autoimmune disease.

Authors:  Istvan Berczi
Journal:  Endocr Pathol       Date:  1993-12       Impact factor: 3.943

3.  Differential effects of d- and l-enantiomers of govadine on distinct forms of cognitive flexibility and a comparison with dopaminergic drugs.

Authors:  Gemma L Dalton; Stan B Floresco; Anthony G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2021-01-11       Impact factor: 4.530

4.  Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALB/c female mice.

Authors:  D H Russell; K T Mills; F J Talamantes; H A Bern
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes.

Authors:  K C Gilmour; R Pine; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro.

Authors:  K Morkawa; F Oseko; S Morikawa
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

7.  Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.

Authors:  T Bauernhofer; I Kuss; U Friebe-Hoffmann; A S Baum; G Dworacki; B K Vonderhaar; T L Whiteside
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

8.  Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen.

Authors:  A R Buckley; P D Crowe; D H Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors.

Authors:  K C Gilmour; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

10.  Identification and functional activity of prolactin receptors in thymic epithelial cells.

Authors:  M Dardenne; P A Kelly; J F Bach; W Savino
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.